Amlan International announced the launch of Varium, a new non-antibiotic formulated product that acts like an antibiotic growth promoter (AGP) for poultry.

In clinical studies, Varium promoted broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function and strengthening the intestinal barrier function.

"Research studies conducted with leading poultry collaborators in the U.S. showed that Varium consistently achieved growth performance equivalent to commercial AGPs and also reduced the effects of bacteria-associated enteric disease," Amlan president Dr. Ron Cravens said.

As the global poultry production community continues to shift to a "no antibiotics ever" approach in light of consumer and regulatory pressures, interest in AGP alternatives that address bird intestinal health while enhancing performance is growing.

Biotoxins produced by microorganisms such as Clostridium perfringens, Escherichia coli and salmonella damage the intestinal barrier, which reduces overall gut health and function, thereby diverting energy from weight gain. Decreased gut function can also cause birds to suffer from lower feed conversion and increased mortality. By focusing on maintaining a healthy intestinal environment, producers are able to maximize the efficiency of their nutritional program.

"Varium has been shown to lower C. perfringens-induced necrotic enteritis lesion scores, improve feed conversion, reduce mortality and support weight gain," Cravens said. "In fact, in clinical trials, Varium provided a (return on investment) of 3:1 or higher by improving feed conversion and decreasing mortality."

Varium is currently approved for use in Peru, Bolivia, Malaysia, Thailand and the Philippines and is awaiting registration approval in multiple other countries in South America, the Middle East and the Asia-Pacific region.